Literature DB >> 33357317

[Research Progress of Circular RNA in Lung Cancer].

Xiangwei Ge1, Zhibo Zhang1, Xiaoyu Zhi1, Jinliang Wang1.   

Abstract

Lung cancer is the most common malignant tumor with the highest morbidity and mortality worldwide, and its imposes an insupportable burden on patients due to its poor prognosis. The diagnosis and treatment of lung cancer is under great pressure. Therefore, it is urgent to explore effective therapeutic targets and molecular markers. Circular RNA (circRNA) is a kind of covalently closed non-coding RNAs, which has attracted much attention due to its conservation, stability and tissue specificity. Many studies have found that circRNA participates in the regulation of lung cancer through various mechanisms such as sponging miRNA and plays a part vital role in the early diagnosis, treatment and prognosis evaluation. In recent years, there have been numerous studies on circRNA in lung cancer. This paper summarizes the current progress of circRNA in the diagnosis, treatment and prognosis of lung cancer.
.

Entities:  

Keywords:  Circular RNA; Diagnosis; Lung neoplasms; Prognosis; Treatment

Year:  2020        PMID: 33357317      PMCID: PMC7786223          DOI: 10.3779/j.issn.1009-3419.2020.102.38

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN: 1009-3419


  55 in total

1.  Exon-intron circular RNAs regulate transcription in the nucleus.

Authors:  Zhaoyong Li; Chuan Huang; Chun Bao; Liang Chen; Mei Lin; Xiaolin Wang; Guolin Zhong; Bin Yu; Wanchen Hu; Limin Dai; Pengfei Zhu; Zhaoxia Chang; Qingfa Wu; Yi Zhao; Ya Jia; Ping Xu; Huijie Liu; Ge Shan
Journal:  Nat Struct Mol Biol       Date:  2015-02-09       Impact factor: 15.369

2.  Downregulated expression of hsa_circ_0037515 and hsa_circ_0037516 as novel biomarkers for non-small cell lung cancer.

Authors:  Dunmei Zhao; Honggang Liu; Huachao Liu; Xueqing Zhang; Meng Zhang; Vijay Kumar Kolluri; Xulong Feng; Zhenglei He; Minghua Wang; Ting'an Zhu; Xiaolong Yan; Yinghui Zhou
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

3.  A novel circular RNA, hsa-circ-0000211, promotes lung adenocarcinoma migration and invasion through sponging of hsa-miR-622 and modulating HIF1-α expression.

Authors:  Dongjie Feng; Youtao Xu; Jingwen Hu; Shuai Zhang; Ming Li; Lin Xu
Journal:  Biochem Biophys Res Commun       Date:  2019-10-25       Impact factor: 3.575

4.  Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer.

Authors:  Yu-Tao Liu; Xiao-Hong Han; Pu-Yuan Xing; Xing-Sheng Hu; Xue-Zhi Hao; Yan Wang; Jun-Ling Li; Zhi-Shang Zhang; Zhi-Hao Yang; Yuan-Kai Shi
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

5.  Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)-182/miR-93-leukemia inhibitory factor receptor pathway.

Authors:  Lin Wang; Yingkuan Liang; Qixing Mao; Wenjie Xia; Bing Chen; Hongyu Shen; Lin Xu; Feng Jiang; Gaochao Dong
Journal:  Cancer Sci       Date:  2019-08-14       Impact factor: 6.716

6.  Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p.

Authors:  Xiaoping Li; Bo Yang; Haixia Ren; Ting Xiao; Liang Zhang; Lei Li; Mingjiang Li; Xuhui Wang; Honggang Zhou; Weidong Zhang
Journal:  Cell Death Dis       Date:  2019-12-16       Impact factor: 8.469

7.  Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells.

Authors:  Peng-Fei Zhang; Xu Pei; Ke-Sang Li; Li-Na Jin; Fei Wang; Jing Wu; Xue-Mei Zhang
Journal:  Mol Cancer       Date:  2019-12-09       Impact factor: 27.401

8.  Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.

Authors:  Nan Gao; Baoguo Ye
Journal:  Cancer Cell Int       Date:  2020-01-03       Impact factor: 5.722

Review 9.  [Research Progress of Circular RNA in Lung Cancer].

Authors:  Yinyu Mu; Fuyi Xie
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-07-20

10.  CircRNA_103762 promotes multidrug resistance in NSCLC by targeting DNA damage inducible transcript 3 (CHOP).

Authors:  Guanhua Xiao; Wenqi Huang; Yongzhong Zhan; Jing Li; Wancheng Tong
Journal:  J Clin Lab Anal       Date:  2020-03-02       Impact factor: 2.352

View more
  1 in total

1.  circCOL1A1 Promotes the Progression of Gastric Cancer Cells through Sponging miR-145 to Enhance RABL3 Expression.

Authors:  Yue Ma; Yanyi Ren; Huitao Wen; Chengcheng Cui
Journal:  J Immunol Res       Date:  2021-09-29       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.